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Medicines: Effectiveness or cost
To the Editor: Regarding the article by Chris Bateman,1 I was 
horrified to see that I am readily identifiable as the journalist’s 
‘source’, as I had officially withdrawn and dissociated myself 
from all aspects of the article. The article is flawed and does not 
reflect the collegial nature of the discussions at provincial and 
national levels. It is ironic that the article attempts to debate 
the ethics of breast cancer drug allocation – but there has been 
a lack of ethical due-process in its publication. The lack of peer 
review is highlighted by the spelling of one of the prominent 
agents involved (i.e. the taxanes), which are spelt ‘texanes’ 
throughout the article.
This letter, however, allows me the opportunity to highlight 
the need for a formal review process for medicines in a 
resource-constrained health care sector, such as our own.
The way in which medicines are usually evaluated in 
the various sectors in South Africa is based on two criteria: 
effectiveness and cost. However, in reality, decisions are 
invariably based on expert opinion. Unfortunately, the 
emphasis is usually on either effectiveness or cost, and 
hardly ever on a systematic analysis that incorporates 
both considerations. There are a number of reasons for 
this behaviour: (i) lack of appreciation of the role of cost-
effectiveness analysis in decision making; (ii) scarcity or 
absence of individuals with the necessary critical appraisal 
skills; and (iii) a short-term view of the consequences of health 
care decisions.
It is imperative that this kind of independent systematic 
analysis takes place for all medicines, so ensuring access, an 
equitable distribution of resources, and justice in the health 
care industry. Such a process will go a long way towards 
establishing an appropriate standard of clinical excellence, 
open to scrutiny. This is a critical ethical imperative in a 
resource-constrained health care system such as South Africa’s, 
and for societal trust in the process.
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Unhygienic male circumcision  
procedures and HIV transmission
To the Editor: Connolly and colleagues report one of the most 
detailed observational investigations of the association between 
male circumcision and HIV infection in sub-Saharan Africa to 
date.1 They found no overall association between circumcision 
and prevalent HIV infection in South Africans. Connolly and 
colleagues also suspect that the often unhygienic circumcision 
procedures among black South Africans may facilitate HIV 
transmission.  
Evidence from Kenya, Lesotho and Tanzania is consistent 
with this hypothesis.2  Circumcised males in these countries 
are typically circumcised in adolescence or early adulthood. 
In each country, circumcised virgins were substantially more 
likely to be HIV infected than sexually experienced males. 
Similarly, circumcised adolescent males were more likely 
to be infected than their uncircumcised counterparts. (In 
Lesothoan young men circumcision was also associated with 
HIV infection, perhaps reflecting an older age at circumcision 
for Lesothoans than for Kenyans and Tanzanians.) However, 
in older age groups circumcised men were less likely to be 
infected than uncircumcised men. This pattern could partially 
be explained by increased mortality among circumcised 
adolescents and young adults (due to circumcision-related 
HIV infection), thus reducing HIV prevalence (or slowing its 
growth) relative to uncircumcised men in older age groups.2 
A delayed protective effect of circumcision, HIV-specific 
immunity acquired from circumcision-related exposures, and 
other factors might also account for this pattern. 
For decades, substantial fractions of youth throughout 
southern and eastern Africa have identified circumcision as a 
risk for HIV transmission.2-10 It is therefore crucial that more 
rigorous investigations beyond analyses of cross-sectional data 
be conducted to resolve the matter with confidence.2 Future 
work might include detailed observations of circumcision 
procedures in different settings combined with prospective 
studies of adolescent and young adult males in communities 
where circumcision is common.  Intervention trials of safer 
circumcision (compared with existing procedures) might also 
provide critical evidence, as might sequencing of infected 
youths’ HIV DNA in both observational and intervention 
studies that focus on circumcision in specific communities.
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Circumcision and HIV
To the Editor: Three articles in the October 2008 SAMJ make 
arguments against the use of male circumcision (MC) as a 
preventive measure to counter the HIV pandemic. There are, 
however, good arguments in favour of MC.
Approximately 40 observational studies were done in the 
1990s. The majority of these showed a significant protective 
effect of MC against HIV acquisition in men.1 This evidence, 
while compelling, was insufficient to promote circumcision 
programmes as health policy. Hence, three randomised 
controlled trials were undertaken in Africa to provide firm 
evidence supporting a protective effect. The study from Orange 
Farm (the largest informal settlement in Gauteng), which 
randomised over 3 000 men, showed a 60% reduction in the 
risk of HIV acquisition in the group circumcised at entry over 
the 2 years of the trial. The other two trials demonstrated 
similar protective effects.
The biological explanation for circumcision’s protective effect 
is the foreskin’s nine times greater absorption of HIV when 
compared with other genital mucosa.2 Langerhans and other 
receptor cells mediate this susceptibility.
Modelling the impact of MC on HIV prevalence has been 
done for Gauteng province. Assuming full coverage of a 
circumcision intervention programme, with a 2005 adult male 
HIV prevalence of 25.6%, then 1 000 circumcisions would avert 
an estimated 308 infections over 20 years. The cost is $181 per 
HIV infection thus averted and a net saving of $2.4 million in 
treatment costs.3
In March 2007, following on from the Orange Farm trial, the 
Joint United Nations Programme on HIV/AIDS (UNAIDS) 
and the World Health Organization (WHO) produced a paper 
that concludes: ‘… promoting male circumcision should 
be recognized as an additional, important strategy for the 
prevention of heterosexually acquired HIV infection in men’.4
The above conclusions do not seem to be the last word on 
the matter, as the WHO has recently published a position 
paper less categorical in its endorsement of MC.5 Chief 
among the concerns are questions of whether trial results 
can be extrapolated to the real world, and issues about the 
practicability of MC interventions in resource-poor settings. 
These debates are surely important and need to continue.
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